Stock options

Meryllion Resources granted 8.4 million stock options to officers, directors, and consultants on January 28, 2026. Each option allows purchase of a common share at $0.08, vesting immediately but subject to a four-month hold. These incentives aim to align key personnel with shareholder interests and support the company’s exploration stage projects in Nevada and Tasmania.

Tincorp Metals has granted 1,055,000 stock options to its directors, officers, employees, and consultants at an exercise price of $0.44 per share. This move, pending regulatory approval, aims to align stakeholder interests with shareholders and encourage long-term commitment. The options vest over three years and are exercisable for five years. This strategy balances incentivizing key personnel with managing potential share dilution, as Tincorp focuses on its tin exploration projects in Bolivia.

Wildsky Resources has granted 2.1 million incentive stock options to its officers, directors, and consultants, with an exercise price of $0.17 per share. These options, expiring in five years, aim to align key personnel with the company’s long-term performance. This strategic compensation move is designed to attract and retain talent within the junior exploration sector. The grant may lead to future dilution depending on option exercise and overall share count.

Renegade Gold granted 3,025,000 stock options to directors, officers, and consultants, exercisable at $0.52 per share for three years. This aims to align executive interests with shareholder value and motivate key personnel as the company advances its exploration projects in the Red Lake Mining District. The immediate vesting encourages engagement, though potential dilution for existing shareholders is a consideration.

Summit Therapeutics has granted stock options to seventeen new employees, allowing them to purchase up to 214,331 shares at $18.66 each. These options have a ten-year term and vest over four years, designed to attract and retain talent in the competitive biopharmaceutical industry. This aligns employee interests with the company’s long-term growth and commitment to developing oncology therapies.

Atomic Minerals Corporation has appointed Lagace Capital for investor relations, starting January 2026. Lagace Capital will manage outreach and communication with investors for a $6,000 monthly retainer and 200,000 stock options. This move aims to boost visibility for Atomic Minerals’ uranium exploration efforts in North America.

words.Scholar Rock (NASDAQ: SRRK) granted inducement equity awards to two new executives—4,457 stock options and 3,343 restricted stock units—under its 2022 Inducement Equity Plan, subject to Nasdaq Listing Rule 5635(c)(4). The options have a $45.25 exercise price and vest 25% after one year, then quarterly; the RSUs vest annually over four years. The awards dilute shareholders by ~0.4% of float and will increase compensation expense. The move aims to attract talent to advance the apitegromab program for SMA and other rare neuromuscular disorders, amid strong biotech market momentum.

Banyan Gold Corp. announced that its board approved 5,060,000 stock options to purchase 5.6 million shares at a $1.00 exercise price, vesting over up to 18 months and expiring after five years, granted to consultants, employees, advisors and exploration staff. The updated Aur Mac mineral‑resource estimate (effective 28 June 2025) reports 2.274 Moz indicated and 5.453 Moz inferred gold. The Hyland project (effective 1 Sept 2025) holds 337 koz indicated gold, 2.63 Moz indicated silver, plus 118 koz gold and 0.86 Moz silver inferred. Upcoming roadshows are scheduled for Toronto (8‑10 Dec 2025) and Houston (21‑23 Dec 2025).

BrandPilot AI settled a $17,272.75 liability by issuing 690,910 Debt Settlement Units—each containing a common share and a warrant exercisable at $0.05 for up to 24 months—at a deemed $0.025 per unit, with a 4‑month‑plus‑1‑day hold. Simultaneously, it granted 2.8 million stock options (exercise $0.05, three‑year vest, exercisable through Dec 1 2030) and 5.05 million RSUs (vesting Dec 1 2028). All awards were made under the omnibus equity incentive plan approved on May 31 2024, aiming to preserve cash and align executive compensation with growth.